Ruifang Yang, PhD
Clinical Cardiac Electrophysiology · Reno, NVNPI 1114388030
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $12,867 of the $19,791 with a category attached, or 65.0%. 11 manufacturers reported payments, led by Philips North America LLC at 30.0% of the total. Reporting peaked in 2024 at $9,888 and has fallen 71.7% since, to $2,798 in 2025.
Across 205 payments — averaging $96.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$6K
- Medtronic$6K
- Boston Scientific$2K
- Abbott$2K
- Biosense Webster, Inc.$2K
- Biotronik Inc.$2K
- plus $740 from 5 others
What the payments were for
- Travel & lodging$12,86765%
- Food & beverage$5,36727%
- Education$1,5578%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 16 | $5,945 |
| Medtronic | 52 | $5,544 |
| Boston Scientific | 19 | $2,349 |
| Abbott | 14 | $1,952 |
| Biosense Webster, Inc. | 85 | $1,723 |
| Biotronik Inc. | 3 | $1,538 |
| Medical Device Business Services, Inc. | 4 | $542 |
| Lantheus Medical Imaging, Inc. | 7 | $123 |
| Cardiva Medical, Inc. | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $23 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$5,211
- AVEIR$1,191
- Carto 3$712
- Solia$617
- BioMonitor$617
- Acticor 7 VR-T DX$617
- Edora 8 DR-T$617
- Rivacor 7 DR-T$617
- ENSITE$310
- ENSITE PRECISION$244
- US Und$233
- Adapta$206
- GENERAL - THERAPIES$172
How this compares
$19,791 in reported general payments places this provider in the 60th percentile of 20 clinical cardiac electrophysiology providers in Nevada.
See all clinical cardiac electrophysiology providers in Nevada →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $31,512 |
| MultaqDronedarone Hcl | 11 | $14,648 |
| Metoprolol Succinate | 32 | $415 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Reno
- Shining SunReno$22K
- Joshua LeichmanReno$17K
- David SmithReno$10K
- Rakesh PaiReno$121
- Robert LesterReno$106
- Claudio BonomettiLas Vegas$89K
- Erik SirulnickLas Vegas$44K
- Niuton KoideLas Vegas$34K
- Daejoon AnhHenderson$33K
- Jeffrey TurnerCarson City$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.